Long-term weight loss for patients with obesity proved mostly successful after taking prescription-only injectable ...

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

However, outside of clinical trials, weight loss data with liraglutide or semaglutide has been limited to a short follow-up period of six months. In the present study, weight outcomes among obese ...

There is soaring demand for weight-loss drugs in the GLP-1 class, and the company will now sell it to certain professions for ...

More Tennessee companies are covering weight-loss injections in health care benefit plans. This could impact the state's high ...

Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months ... as oral semaglutide in less time. Results from a later-stage study are expected in the first half of ...

U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...

Semaglutide ... after 12 months of use, which equates to 49.4lb (22.4kg). Their BMI decreased by 7.5kg/m 2, on average after 12 months. Dr. Snell-Bergeon says, "This amount of weight loss has ...